share_log

Brainstorm Cell Therapeutics To Carry Out 1-for-15 Reverse Stock Split On October 1st, 2024

Moomoo News ·  Sep 27 19:35

September 27th (Eastern Time) - $Brainstorm Cell Therapeutics (BCLI.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from October 1st, 2024.

$Brainstorm Cell Therapeutics (BCLI.US)$ rose 4.26% and closed at $0.2545 on September 26th with a turnover of $44,603. $Brainstorm Cell Therapeutics (BCLI.US)$ now has a total market capitalization of $20.29 million.


What Is a Reverse Stock Split?

A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.

Note:

The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment